Art Papier, M.D., CEO of VisualDx, says darker skin tones have been underrepresented in dermatology resources for decades and ...

The American Academy of Ophthalmology (AAO) kicked off their 2026 annual meeting today in New Orleans, with an authentic second-line parade of musicians, dancers and performers inviting conference ...

Large language models (LLMs) are now bringing new attention to the category, according to Art Papier, M.D., CEO of VisualDx. He also cautions that clinicians shouldn’t assume these tools are always ...

Real-world data at the 2026 Fall Clinical Dermatology Conference show dupilumab in children with atopic dermatitis cuts new ...

Yuqian Liu | Authors | Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need isotretinoin. Sagimet Biosciences’ denifanstat oral acne pill shows rapid, ...

Experts at Fall Clinical Derm 2026 urge early JAK inhibitors over systemic steroids for atopic dermatitis and long-term vitiligo treatment, saying boxed-warning risks are overstated. It’s recommended ...

Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need ...

Diabetes drives 25% of U.S. healthcare spending; see how CGM tech cuts finger sticks and shifts costs for patients and payers.

The 2026 Pharmacy Benefit Management Institute Annual National Conference was held Sept. 10-11 in Orlando, Florida. Here is a ...

Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, ...

Sagimet Biosciences has begun screening patients for a U.S. phase 3 trial of denifanstat, an investigational once-daily oral ...